Lin Bingzhen, Kolluri Siva Kumar, Lin Feng, Liu Wen, Han Young-Hoon, Cao Xihua, Dawson Marcia I, Reed John C, Zhang Xiao-kun
The Burnham Institute, Cancer Center, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
Cell. 2004 Feb 20;116(4):527-40. doi: 10.1016/s0092-8674(04)00162-x.
The Bcl-2 family proteins are key regulators of apoptosis in human diseases and cancers. Though known to block apoptosis, Bcl-2 promotes cell death through an undefined mechanism. Here, we show that Bcl-2 interacts with orphan nuclear receptor Nur77 (also known as TR3), which is required for cancer cell apoptosis induced by many antineoplastic agents. The interaction is mediated by the N-terminal loop region of Bcl-2 and is required for Nur77 mitochondrial localization and apoptosis. Nur77 binding induces a Bcl-2 conformational change that exposes its BH3 domain, resulting in conversion of Bcl-2 from a protector to a killer. These findings establish the coupling of Nur77 nuclear receptor with the Bcl-2 apoptotic machinery and demonstrate that Bcl-2 can manifest opposing phenotypes, induced by interactions with proteins such as Nur77, suggesting novel strategies for regulating apoptosis in cancer and other diseases.
Bcl-2家族蛋白是人类疾病和癌症中细胞凋亡的关键调节因子。虽然已知Bcl-2可阻断细胞凋亡,但它通过一种不明机制促进细胞死亡。在此,我们表明Bcl-2与孤儿核受体Nur77(也称为TR3)相互作用,Nur77是许多抗肿瘤药物诱导癌细胞凋亡所必需的。这种相互作用由Bcl-2的N端环区域介导,是Nur77线粒体定位和凋亡所必需的。Nur77结合诱导Bcl-2构象变化,暴露其BH3结构域,导致Bcl-2从保护者转变为杀手。这些发现确立了Nur77核受体与Bcl-2凋亡机制的耦合,并证明Bcl-2可表现出由与Nur77等蛋白质相互作用诱导的相反表型,为调控癌症和其他疾病中的细胞凋亡提供了新策略。